HOME >> MEDICINE >> NEWS
4D proton therapy, radiation-resistant tumors, interpreting medical images

ant Secretary of Washington State's Division of Environmental Health, will describe emergency preparedness and terrorism response training for professionals at the statewide level. On Thursday, July 28, at 10:00 AM, Debra McBaugh, the chairperson of the Conference of Radiation Control Program Directors, will discuss how medical physicists have unique skills that can assist states in terrorism response. McBaugh was part of the State of Washington's team that participated in a national exercise that included responding to a simulated dirty bomb attack. Other sessions throughout the week cover topics such as how Medicare and Medicaid reform are affecting insurance reimbursement of radiological procedures, medical errors, the impact of recent Nuclear Regulatory Commission training and experience regulations on the handlers of radioactive material in diagnosis and therapy, and reforms in the radiological health programs at the FDA.

HIGHLIGHTS OF THE SCIENTIFIC PROGRAM

The following is a sampling of some of the many noteworthy talks that medical physicists will present at the meeting.

I. PROMISING FIRST IMAGES FROM HUMAN CLINICAL TRIALS OF MAMMOGRAPHY ALTERNATIVE
II. LIGHTING UP RADIATION-RESISTANT TUMOR REGIONS
III. READING BETWEEN THE LINES OF MEDICAL-IMAGE INTERPRETATION
IV. TREATING LUNG CANCER WITH 4D PROTONS
V. HYBRID MACHINE PERFORMS MRI AND RADIATION THERAPY
VI. ELECTRON TECHNIQUE IMAGES CRUCIAL OXYGEN LEVELS

I. PROMISING FIRST IMAGES FROM HUMAN CLINICAL TRIALS OF MAMMOGRAPHY ALTERNATIVE

Researchers will present some of the first images from human clinical trials of breast CT imaging, a potential improvement over traditional mammography that aims to catch breast cancer earlier while eliminating patient discomfort. Traditional mammograms involve squeezing the breast between two plates and firing an x-ray that images the breast all at o
'"/>


28-Jun-2005


Page: 1 2 3 4 5 6 7 8 9

Related medicine news :

1. Antiprotons 4 times more effective than protons for cell irradiation
2. New proton therapy, breast CT clinical trials, radiation-resistant tumors
3. Study compares stomach acid control of three proton pump inhibitors in chronic NSAID users
4. RNAi shows promise in gene therapy, Stanford researcher says
5. Genomic tests improve prediction of breast cancer response to chemotherapy, hormonal therapy
6. Order of chemotherapy, radiation has no effect on breast cancer survival
7. Almost 1/3 of colon cancer patients stop chemotherapy, leading to double the death rate
8. No link between estrogen-only therapy, breast cancer in postmenopausal women
9. Talk therapy more effective long term treatment for SAD than light therapy, study finds
10. Star Trek-type scanning may reveal genetic activity of tumors, Stanford study shows
11. Blacks with bladder cancer have more aggressive tumors, worse survival, U-M study finds

Post Your Comments:
(Date:4/23/2014)... of endogenous neural precursor cells cannot alone compensate ... the perspective of neural plasticity, Dr. Yun Xiang ... observed the effects of functional electrical stimulation treatment ... of basic fibroblast growth factor and epidermal growth ... side. The researchers found that functional electrical stimulation ...
(Date:4/22/2014)... (Chicago) A recently FDA-approved device has been shown ... as much as 50 percent. When coupled with an ... Rush, the device facilitated the complete elimination of seizures ... in the decade-long clinical trials. , That,s good news ... in the U.S. living with epilepsy whose seizures can,t ...
(Date:4/22/2014)... all lung cancers are small cell lung cancers ... to chemotherapy. However, researchers at Virginia Commonwealth University ... the mechanisms leading to this resistance that may ... primarily by mediating B-cell lymphoma 2 (Bcl-2) family ... Depending on their function, this family of proteins ...
(Date:4/22/2014)... Hopkins scientists have found a way to block abnormal ... of atherosclerosis, the main cause of heart attacks and ... The condition develops when fat builds inside blood vessels ... greatly reducing their ability to feed oxygen-rich blood to ... series of experiments, described April 7 in the journal ...
(Date:4/22/2014)... massive health care spending, a new RAND study concludes ... incentivize pharmaceutical companies and device makers to develop products ... medical technologies and their use, a new study suggests ... medical devices get created in the first place. The ... as little loss of health as possible and to ...
Breaking Medicine News(10 mins):Health News:Newly approved brain stimulator offers hope for individuals with uncontrolled epilepsy 2Health News:Scientists pinpoint protein that could improve small cell lung cancer therapies 2Health News:Scientists alter fat metabolism in animals to prevent most common type of heart disease 2Health News:Scientists alter fat metabolism in animals to prevent most common type of heart disease 3Health News:Scientists alter fat metabolism in animals to prevent most common type of heart disease 4Health News:US medical innovation needs smarter incentives to cut health spending, study finds 2Health News:US medical innovation needs smarter incentives to cut health spending, study finds 3
(Date:1/15/2014)... PHILADELPHIA , Jan. 15, 2014  Echo Therapeutics, Inc. ... company developing its Symphony® CGM System as a non-invasive, ... Robert F. Doman , Executive Chairman and Interim CEO ... Capital Markets, Tenth Annual Equity Conference. ...
(Date:1/15/2014)... Jan. 15, 2014 Reportlinker.com announces that ... in its catalogue: ... and Market Analysis to 2022 ... Dermatitis - India Drug Forecast and Market ...
(Date:1/15/2014)... 2014  Zafgen, Inc., a leading biopharmaceutical company dedicated ... patients, today announced initial results from its Phase ... methionine aminopeptidase 2 (MetAP2), in patients with Prader-Willi ...  These results showed improvements in body weight, hunger-related ...
Breaking Medicine Technology:Echo Therapeutics to Present at the Noble Financial Capital Markets' Tenth Annual Equity Conference 2Echo Therapeutics to Present at the Noble Financial Capital Markets' Tenth Annual Equity Conference 3PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 2PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 3PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 4PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 5Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 2Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 3Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 4
Cached News: